Kateřina Holá

Kateřina Holá

Auto-generated profile, based on publicly available information

Kateřina Holá

Department of Oncology, University Hospital, Olomouc, Czech Republic

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2016 in Chemical Reviews
Verified
Journal Article
Open access
KUKarel Ulbrich
Karel Ulbrich
KHKateřina Holá
Kateřina Holá
VŠVladimir Šubr
Vladimir Šubr
Aristides BakandritsosAristides Bakandritsos
Aristides Bakandritsos
JTJiří Tuček
Jiří Tuček
Radek ZbořilRadek Zbořil
Radek Zbořil
Targeted delivery combined with controlled drug release has a pivotal role in the future of personalized medicine. This review covers the principles, advantages, and drawbacks of passive and active targeting based on various polymer and magnetic iron oxide nanoparticle carriers with drug attached by both covalent and noncovalent pathways. Attention is devoted to the tailored conjugation of targeting ligands (e.g., enzymes, antibodies, peptides) to drug carrier systems. Similarly, the approaches toward controlled drug release are discussed. Various polymer–drug conjugates based, for example, on polyethylene glycol (PEG), N-(2-hydroxypropyl)methacrylamide (HPMA), polymeric micelles, and nanoparticle carriers are explored with respect to absorption, distribution, metabolism, and excretion (ADME scheme) of administrated drug. Design and structure of superparamagnetic iron oxide nanoparticles (SPION) and condensed magnetic clusters are classified according to the mechanism of noncovalent drug loading involving hydrophobic and electrostatic interactions, coordination chemistry, and encapsulation in porous materials. Principles of covalent conjugation of drugs with SPIONs including thermo- and pH-degradable bonds, amide linkage, redox-cleavable bonds, and enzymatically-cleavable bonds are also thoroughly described. Finally, results of clinical trials obtained with polymeric and magnetic carriers are analyzed highlighting the potential advantages and future directions in targeted anticancer therapy.

1 October 2014 in Nano Today
Verified
Journal Article
Closed access
KHKaterina Hola
Katerina Hola
YZYu Zhang
Yu Zhang
YWYu Wang
Yu Wang
EGEmmanuel P. Giannelis
Emmanuel P. Giannelis
Radek ZbořilRadek Zbořil
Radek Zbořil
ARAndrey L. Rogach
Andrey L. Rogach

20 November 2017 in ACS Nano
Verified
Journal Article
Closed access
KHKateřina Holá
Kateřina Holá
MSMária Sudolská
Mária Sudolská
SKSergii Kalytchuk
Sergii Kalytchuk
DNDana Nachtigallová
Dana Nachtigallová
Andrey L. RogachAndrey L. Rogach
Andrey L. Rogach
Radek ZbořilRadek Zbořil
Radek Zbořil

21 November 2018 in Light: Science & Applications
Verified
Journal Article
Open access
PDF file
XBXin Bao
Xin Bao
YYYe Yuan
Ye Yuan
JCJingqin Chen
Jingqin Chen
BZBohan Zhang
Bohan Zhang
DLDi Li
Di Li
SQSongnan Qu
Songnan Qu
Carbon dots that exhibit near-infrared fluorescence (NIR CDs) are considered emerging nanomaterials for advanced biomedical applications with low toxicity and superior photostability and targeting compared to currently used photoluminescence agents. Despite progress in the synthesis of NIR CDs, there remains a key obstacle to using them as an in vivo theranostic agent. This work demonstrates that the newly developed sulfur and nitrogen codoped NIR CDs are highly efficient in photothermal therapy (PTT) in mouse models (conversion efficiency of 59%) and can be readily visualized by photoluminescence and photoacoustic imaging. The real theranostic potential of NIR CDs is enhanced by their unique biodistribution and targeting. Contrary to all other nanomaterials that have been tested in biomedicine, they are excreted through the body’s renal filtration system. Moreover, after intravenous injection, NIR CDs are accumulated in tumor tissue via passive targeting, without any active species such as antibodies. Due to their accumulation in tumor tissue without the need for intratumor injection, high photothermal conversion, excellent optical and photoacoustic imaging performance, and renal excretion, the developed CDs are suitable for transfer to clinical biomedical practice.

1 April 2016 in Carbon
Verified
Journal Article
Closed access
MHMarketa Havrdova
Marketa Havrdova
KHKaterina Hola
Katerina Hola
JSJosef Skopalik
Josef Skopalik
KTKaterina Tomankova
Katerina Tomankova
MPMartin Petr
Martin Petr
Radek ZbořilRadek Zbořil
Radek Zbořil

1 November 2015 in Biotechnology Advances
Verified
Journal Article
Closed access
KHKaterina Hola
Katerina Hola
ZMZdenka Markova
Zdenka Markova
GZGiorgio Zoppellaro
Giorgio Zoppellaro
JTJiri Tucek
Jiri Tucek
Radek ZbořilRadek Zbořil
Radek Zbořil